Advertisement

Related Videos

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Deborah Collyar: What's In It for Patients?

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Advertisement

Advertisement




Oct
06
Today In Oncology
Impact of Proton and Photon Therapy on HRQOL in Breast Cancer
Older Women With High-Risk Breast Cancer Addition of Adjuvant Chemotherapy to Hormone Therapy
Study Shows That After Early Breast Cancer Diagnosis, Risk of a Second Cancer is Low
Advanced or Metastatic Breast Cancer: FDA Approves Imlunestrant for ER-Positive, HER2-Negative, ESR1-Mutated Disease
Use of Obecabtagene Autoleucel CAR T-Cell Therapy for B-Cell Acute Lymphocytic Leukemia
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo